We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Medical Students Trained in Genomics and Personalized Medicine

By LabMedica International staff writers
Posted on 14 Jul 2010
Doctors have recommended that genomics and personalized medicine become a core competency for all pathology trainees by 2012.

As a first step in leading this program, the department of pathology at Beth Israel Deaconess Medical Center (BIDMC; Boston, MA; USA) in collaboration with BIDMC's genetic counseling service, last year launched the Genomic Medicine Initiative, a compulsory program to prepare doctors-in-training to apply genomics and personalized medicine in their day-to-day practices.

Jeffrey Saffitz, M.D., Ph.D., and colleagues wrote in a special article in the June, 2010 edition of the American Journal Of Clinical Pathology (AJCP), "Genomics and 'medical sequencing' will revolutionize clinical laboratory diagnostics as the foundation for the new era of personalized medicine.....Pathologists must take the lead in the application of genomics technologies, including whole genome sequencing, laboratory technologies, and personalized medicine."

The new BIDMC pathology curriculum addresses these issues, with the new medical specialty built on three pillars: laboratory medicine, genetic counseling, and health information technology. More...
Richard Schwartzstein, M.D., vice president for education at BIDMC and a faculty dean for medical education at Harvard Medical School (Boston, MA, USA), explained, "The integration of genetic information will be the core of 'patient-centered' care."

Related Links:

Beth Israel Deaconess Medical Center
Harvard Medical School



New
Gold Member
Aspiration System
VACUSAFE
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Repetitive Pipette
VWR® Stepper Pro
New
Urine Analyzer
respons® UDS100
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Accurate immunotherapy selection for esophageal and GEJ carcinomas depends on consistent PD-L1 assessment (credit: Adobe Stock)

FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas

Esophageal and gastroesophageal junction carcinomas (GEJ) have a poor prognosis, with approximately 16,250 deaths in the United States in 2025 and a five-year relative survival of 21.9%.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.